Login to Your Account

Other News To Note

Wednesday, April 24, 2013

• Santaris Pharma A/S, of Hoersholm, Denmark, said the European Patent Office issued minutes of the oral proceedings specifying the board of appeal's decision to maintain EP 1015469, the "Wengel" patent, with claims to amino- and thio-LNA nucleotides and oligonucleotides.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription